2024 全體會議 (主題演講)
FDA Perspectives: Trends and Challenges
FDA 觀點:趨勢與挑戰
Courtney H. Lias, PhD
Acting Director, OHT7: Office of in vitro Diagnostic Devices,
United States Food and Drug Administration (FDA)
2024 年全體會議爐邊談話: LDT:
Proposed Rule, Reclassification Activities, Potential Impact and Path Forward
擬議規則、重新分類活動、潛在影響和未來方向
MODERATOR: B. Melina Cimler, PhD, CEO & Founder, PandiaDx LLC
PANELISTS: Stefan Burde, PhD, Director, Global Strategic Business Development, TÜV SÜD America, Inc.; Girish Putcha, MD, PhD, Principal & Founder, Precision Medicine & Diagnostics; Lakshman Ramamurthy, PhD, Vice President Regulatory Affairs, GRAIL; Anna Scrimenti, Associate Director, Public Policy & Advocacy, Association for Molecular Pathology
Next Generation Summit 2024盛況